Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which dominate the weight loss drug market.

A recent study that focused on women under 55 years old found an increase in pancreatic cancer cases.Mercy Medical Center Dr.

Liver cancer is a leading cause of cancer-related deaths worldwide, with distinct geographic patterns in its incidence. In particular, China bears a disproportionate share of the global burden. The ...

Nearly nine in 10 Kiwi kids endure some kind of trauma before turning 8 – be it bullying, parental drug or alcohol addiction, ...

Today saw a dramatic shift of position as advertising watchdogs revealed the looming ban on HFSS and junk food ads, due to ...

A new study links ultra-processed foods to shrinking jaw sizes and dental issues such as buck teeth in children. Researchers ...

As drugs emerge as vital to the Government’s anti-obesity strategy, BBC Panorama sheds light on the pharmaceuticals industry behind them ...

The latest buzz around the popular weight loss drugs Ozempic, Mounjaro and Wegovy is to reduce the doseage to avoid the ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Obesity is an important health issue for patients with chronic kidney disease, speeding its progression, contributing to ...

CEO Dave Ricks said Monday that the company's weight-loss pill orforglipron could receive FDA approval as soon as early 2026. Read more here.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...